One-and-Done: new MRI-Guided radiation could transform liver cancer treatment
NCT ID NCT07223307
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing a new way to deliver radiation therapy for liver cancer. Instead of multiple sessions over weeks, patients receive a single, high-dose treatment guided by real-time MRI scans. The approach aims to be more precise and convenient. The trial will enroll 62 adults with certain types of liver cancer to see if this method improves survival and reduces side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HCC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stanford University
RECRUITINGPalo Alto, California, 94304, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can sound waves supercharge immunotherapy against bile duct cancer?
- Could a vaccine help fight Hard-to-Treat cancers?
- A new test could reveal how radiation affects the liver
- A new clue in the fight against colorectal cancer recurrence?
- Ancient wisdom meets modern oncology: can TCM body types forecast treatment side effects?
- Can blood tests reveal how liver and bile duct cancers respond to treatment?